147 related articles for article (PubMed ID: 1672606)
1. Increased blink rates in schizophrenics. Influences of neuroleptics and psychopathology.
Mackert A; Flechtner KM; Woyth C; Frick K
Schizophr Res; 1991; 4(1):41-7. PubMed ID: 1672606
[TBL] [Abstract][Full Text] [Related]
2. Increased blink rate in drug-naive acute schizophrenic patients.
Mackert A; Woyth C; Flechtner KM; Volz HP
Biol Psychiatry; 1990 Jun; 27(11):1197-202. PubMed ID: 2354226
[TBL] [Abstract][Full Text] [Related]
3. Changes in blink rates of Nigerian schizophrenics treated with chlorpromazine.
Adamson TA
West Afr J Med; 1995; 14(4):194-7. PubMed ID: 8634222
[TBL] [Abstract][Full Text] [Related]
4. [Increased blink rate in schizophrenic patients].
Mackert A; Woyth C; Flechtner KM; Frick K
Nervenarzt; 1990 Jul; 61(7):426-30. PubMed ID: 1975431
[No Abstract] [Full Text] [Related]
5. Eye-blinking and cerebral ventricular size in chronic schizophrenic patients.
Kleinman JE; Karson CN; Weinberger DR; Freed WJ; Berman KF; Wyatt RJ
Am J Psychiatry; 1984 Nov; 141(11):1430-2. PubMed ID: 6149700
[TBL] [Abstract][Full Text] [Related]
6. Blink rate in childhood schizophrenia spectrum disorder.
Caplan R; Guthrie D
Biol Psychiatry; 1994 Feb; 35(4):228-34. PubMed ID: 7910486
[TBL] [Abstract][Full Text] [Related]
7. Auditory event-related potentials and electrodermal activity in medicated and unmedicated schizophrenics.
Roth WT; Goodale J; Pfefferbaum A
Biol Psychiatry; 1991 Mar; 29(6):585-99. PubMed ID: 1675890
[TBL] [Abstract][Full Text] [Related]
8. The influence of neuroleptics on specific syndromes and symptoms in schizophrenics with unfavourable long-term course. A 5-year follow-up study of 50 chronic schizophrenics.
Beckmann H; Fritze J; Franzek E
Neuropsychobiology; 1992; 26(1-2):50-8. PubMed ID: 1361971
[TBL] [Abstract][Full Text] [Related]
9. Blink rate and blunted affect among chronic schizophrenic patients.
Kitamura T; Kahn A; Kumar R; Mackintosh JH
Biol Psychiatry; 1984 Mar; 19(3):429-34. PubMed ID: 6722233
[No Abstract] [Full Text] [Related]
10. Orthostatic challenge during neuroleptic test dose: a possible predictor of short-term outcome.
Volz HP; Mackert A; Diefenbacher A; Friedrich A; Gaebel W; Müller H; Stock G; Möller HJ
Neuropsychobiology; 1994; 30(2-3):94-100. PubMed ID: 7800170
[TBL] [Abstract][Full Text] [Related]
11. First month of neuroleptic treatment in schizophrenia: only partial normalization of the late positive components of visual ERP.
Mintz M; Hermesh H; Glicksohn J; Munitz H; Radwan M
Biol Psychiatry; 1995 Mar; 37(6):402-9. PubMed ID: 7772649
[TBL] [Abstract][Full Text] [Related]
12. Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics.
Spohn HE; Coyne L; Lacoursiere R; Mazur D; Hayes K
Arch Gen Psychiatry; 1985 Sep; 42(9):849-59. PubMed ID: 2864028
[TBL] [Abstract][Full Text] [Related]
13. Electroencephalography in schizophrenic patients: comparison between neuroleptic-naive state and after treatment.
Nagase Y; Okubo Y; Toru M
Biol Psychiatry; 1996 Sep; 40(6):452-6. PubMed ID: 8879464
[TBL] [Abstract][Full Text] [Related]
14. Do neuroleptics impair learning in schizophrenic patients?
Cutmore TR; Beninger RJ
Schizophr Res; 1990; 3(3):173-86. PubMed ID: 1980612
[TBL] [Abstract][Full Text] [Related]
15. Symptomatology and electrodermal activity as predictors of neuroleptic response in young male schizophrenic inpatients.
Lindström EM; Ohlund LS; Lindström LH; Ohman A
Psychiatry Res; 1992 May; 42(2):145-58. PubMed ID: 1352902
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic prescription for Chinese schizophrenics in Hong Kong.
Chiu H; Lee S; Leung CM; Wing YK
Aust N Z J Psychiatry; 1992 Jun; 26(2):262-4. PubMed ID: 1353673
[TBL] [Abstract][Full Text] [Related]
17. Skin conductance responding in schizophrenic patients with abnormal involuntary movements.
Mintz M; Alfisi S; Sigal M
Psychiatry Res; 1990 Oct; 34(1):19-27. PubMed ID: 1980017
[TBL] [Abstract][Full Text] [Related]
18. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
Chouinard G; Annable L; Jones BD; Collu R
Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic dose and schizophrenic symptoms. A survey of prescribing practices.
Peralta V; Cuesta MJ; Caro F; Martinez-Larrea A
Acta Psychiatr Scand; 1994 Nov; 90(5):354-7. PubMed ID: 7872040
[TBL] [Abstract][Full Text] [Related]
20. High-dose destyrosine-gamma-endorphin in tardive dyskinesia.
Korsgaard S; Casey DE; Gerlach J
Psychopharmacology (Berl); 1982; 78(3):285-6. PubMed ID: 6130557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
